Suppr超能文献

[普罗布考治疗高脂血症]

[Probucol treatment of hyperlipidemia].

作者信息

Koizumi J

机构信息

Second Department of Internal Medicine, School of Medicine, Kanazawa University.

出版信息

Nihon Rinsho. 1994 Dec;52(12):3279-84.

PMID:7853723
Abstract

Probucol lowers total and LDL cholesterol levels, and also lowers HDL cholesterol levels. Probucol is able to lower cholesterol levels in homozygous patients with familial hypercholesterolemia as well as in heterozygous patients. In heterozygous familial hypercholesterolemia, probucol lowered total cholesterol levels by 22%, LDL-cholesterol levels by 17%, and HDL-cholesterol levels by 40%, respectively. The lowering HDL cholesterol levels by probucol may reflect increased reverse cholesterol transport. Probucol increases cholesteryl ester transfer protein concentration, and diminishes HDL particle size. Probucol has been reported to retard and even regress atherosclerosis in animal models and to diminish tendinous xanthomas in man. Its lowering LDL-cholesterol levels, activation of reverse cholesterol transport process, and antioxidant effects may cause an antiatherogenic action.

摘要

普罗布考可降低总胆固醇和低密度脂蛋白胆固醇水平,同时也会降低高密度脂蛋白胆固醇水平。普罗布考能够降低纯合子家族性高胆固醇血症患者以及杂合子患者的胆固醇水平。在杂合子家族性高胆固醇血症患者中,普罗布考分别使总胆固醇水平降低22%,低密度脂蛋白胆固醇水平降低17%,高密度脂蛋白胆固醇水平降低40%。普罗布考降低高密度脂蛋白胆固醇水平可能反映了胆固醇逆向转运增加。普罗布考可增加胆固醇酯转运蛋白浓度,并减小高密度脂蛋白颗粒大小。据报道,普罗布考在动物模型中可延缓甚至逆转动脉粥样硬化,并减少人体的肌腱黄色瘤。其降低低密度脂蛋白胆固醇水平、激活胆固醇逆向转运过程以及抗氧化作用可能导致抗动脉粥样硬化作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验